TREAD: TReatment with Exercise Augmentation for Depression: Study rationale and design

Madhukar H. Trivedi, Tracy L. Greer, Bruce D. Grannemann, Timothy S. Church, Daniel I. Galper, Prabha Sunderajan, Stephen R. Wisniewski, Heather O. Chambliss, Alexander N. Jordan, Carrie Finley, Thomas J. Carmody

Research output: Contribution to journalReview article

67 Scopus citations

Abstract

Background: Despite recent advancements in the pharmacological treatment of major depressive disorder (MDD), over half of patients who receive treatment with antidepressant medication do not achieve full remission of symptoms. There is evidence that exercise can reduce depressive symptomatology when used as a treatment for MDD. However, no randomized controlled trials have evaluated exercise as an augmentation strategy for patients with carefully diagnosed MDD who remain symptomatic following an adequate acute phase trial of antidepressant therapy. Purpose: TReatment with Exercise Augmentation for Depression (TREAD) is an NIMH-funded, randomized, controlled trial designed to assess the relative efficacy of two doses of aerobic exercise to augment selective serotonin reuptake inhibitor (SSRI) treatment of MDD. Methods: The TREAD study includes 12 weeks of acute phase treatment with a 12-week post-treatment follow-up. In addition to looking at change in depressive symptoms as a primary outcome, it also includes comprehensive assessment of psychosocial function and treatment adherence. Results: This paper reviews the rationale and design of TREAD and illustrates how we address several key issues in contemporary patient-oriented research on MDD: 1) the use of augmentation strategies in the treatment of depressive disorders in general, 2) the use of non-pharmacological strategies in the treatment of depressive disorders, 3) the considerations of designing a well-controlled trial using two active treatment groups, and 4) the implementation of an adherence program for the use of exercise as a treatment strategy. Conclusions: The TREAD study is uniquely designed to overcome sources of potential bias and threats to internal and external validity that have limited prior research on the mental health effects of exercise. The study is facilitated by the development of a multidisciplinary research team that includes experts in both depression treatment and exercise physiology, as well as other related fields.

Original languageEnglish (US)
Pages (from-to)291-305
Number of pages15
JournalClinical Trials
Volume3
Issue number3
DOIs
StatePublished - Jul 27 2006

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'TREAD: TReatment with Exercise Augmentation for Depression: Study rationale and design'. Together they form a unique fingerprint.

  • Cite this

    Trivedi, M. H., Greer, T. L., Grannemann, B. D., Church, T. S., Galper, D. I., Sunderajan, P., Wisniewski, S. R., Chambliss, H. O., Jordan, A. N., Finley, C., & Carmody, T. J. (2006). TREAD: TReatment with Exercise Augmentation for Depression: Study rationale and design. Clinical Trials, 3(3), 291-305. https://doi.org/10.1191/1740774506cn151oa